Types of jaunildice and bilirubin metabolism

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

I now have all the information needed for a thorough, well-illustrated answer. Let me compile everything.

Jaundice: Types and Bilirubin Metabolism

Jaundice (icterus) is yellow discoloration of the skin, sclerae, and mucous membranes caused by hyperbilirubinemia. It becomes clinically apparent when serum bilirubin exceeds ~2-3 mg/dL.

Part 1: Bilirubin Metabolism

Step 1 - Bilirubin Production (Periphery)

Normal adults produce ~4 mg of bilirubin per kg body weight per day. 70-90% comes from hemoglobin degradation in senescent red blood cells, processed by the mononuclear phagocytic system (spleen, liver, bone marrow). The remainder comes from turnover of non-hemoglobin hemoproteins (myoglobin, cytochrome P-450, catalase, peroxidase).

Two-step conversion of heme to bilirubin:

Heme to Bilirubin conversion - Ganong's Review of Medical Physiology

Heme oxygenase cleaves the heme molecule at its alpha-bridge carbon → produces biliverdin (green tetrapyrrole) + CO + Fe³⁺. This reaction requires NADPH + O₂.
Biliverdin reductase reduces biliverdin → bilirubin (yellow). This requires NADPH.

Note: Biliverdin cannot cross the placenta. Its reduction to bilirubin in mammals allows transplacental removal of fetal bilirubin into the maternal circulation. (Goldman-Cecil Medicine)

Step 2 - Transport to the Liver

Unconjugated bilirubin (UCB) is water-insoluble and is transported in plasma tightly bound to albumin. Certain drugs (salicylates, sulfonamides, furosemide, radiographic contrast agents) can competitively displace bilirubin from albumin - clinically important in neonates where free bilirubin increases the risk of kernicterus.

Step 3 - Hepatic Uptake and Conjugation

Hepatocyte bilirubin handling - Ganong's Review of Medical Physiology

The liver processes bilirubin in four distinct steps:

Step	Process	Key Players
1	Hepatocellular uptake	OATP (organic anion transporting polypeptide) family transporters; carrier-mediated, facilitated diffusion
2	Intracellular binding	Glutathione-S-transferases (ligandins) keep bilirubin in solution inside the hepatocyte
3	Conjugation	UDP-glucuronosyltransferase (UGT1A1) conjugates bilirubin with 1-2 glucuronic acid moieties → bilirubin monoglucuronide (BMG) and diglucuronide (BDG); makes it water-soluble
4	Biliary excretion	MRP2 (ABCC2) actively transports conjugated bilirubin across the canalicular membrane into bile; some refluxes back via MRP3 → OATP1B1/1B3 re-uptake (enterohepatic cycling)

Hepatocellular bilirubin transport - Harrison's Principles of Internal Medicine

Step 4 - Intestinal Processing and Enterohepatic Circulation

Conjugated bilirubin enters the intestine and cannot be reabsorbed (intestinal mucosa is relatively impermeable to it).
Intestinal bacteria convert conjugated bilirubin → urobilinogen (colorless) → urobilin (brown, gives stool its color) and stercobilin.
A portion of urobilinogen is reabsorbed into the portal circulation (enterohepatic circulation); some is re-excreted by the liver, small amounts enter systemic circulation and are excreted in urine (urobilinogen in urine = normal).

Step 5 - Renal Handling

Unconjugated bilirubin: NOT excreted in urine (too tightly albumin-bound for glomerular filtration; no tubular secretion mechanism).
Conjugated bilirubin: Readily filtered at the glomerulus → appears in urine ("bilirubinuria") in conditions with conjugated hyperbilirubinemia. Kidneys act as an "overflow valve" for conjugated bilirubin.

Part 2: Classification of Jaundice

Jaundice is classified by the site of the defect in bilirubin metabolism:

Type 1: Pre-Hepatic (Hemolytic) Jaundice

Mechanism: Excessive bilirubin production overwhelms normal hepatic processing.

Feature	Detail
Bilirubin type	Predominantly unconjugated (indirect)
Urine bilirubin	Absent (unconjugated is albumin-bound, not filtered)
Urine urobilinogen	Markedly increased
Stool color	Dark (increased stercobilin)
Serum bilirubin	Rarely exceeds ~4 mg/dL in isolated hemolysis (liver can compensate up to ~8x normal RBC production); higher values suggest concurrent hepatic dysfunction
LFTs	Normal (AST, ALT, ALP normal)

Causes:

Hemolytic anemias (autoimmune, sickle cell, hereditary spherocytosis, G6PD deficiency)
Malaria, transfusion reactions
Ineffective erythropoiesis (thalassemia)
Resorption of large hematomas

Type 2: Hepatic (Hepatocellular) Jaundice

Mechanism: Liver parenchymal damage impairs uptake, conjugation, and/or excretion of bilirubin.

Feature	Detail
Bilirubin type	Both conjugated and unconjugated elevated
Urine bilirubin	Present (conjugated bilirubin spills into urine)
Urine urobilinogen	Variable (may be increased early, decreased in severe disease)
Stool color	Pale (reduced excretion)
LFTs	Elevated AST, ALT (hepatocyte damage); ALP mildly elevated

Causes: Viral hepatitis (A, B, C), alcoholic hepatitis, cirrhosis, drug-induced hepatotoxicity, autoimmune hepatitis, liver failure.

Type 3: Post-Hepatic (Obstructive/Cholestatic) Jaundice

Mechanism: Obstruction of bile flow (intrahepatic or extrahepatic) prevents conjugated bilirubin from entering the gut.

Feature	Detail
Bilirubin type	Predominantly conjugated (direct)
Urine bilirubin	Strongly positive ("dark urine")
Urine urobilinogen	Absent or markedly reduced (no bilirubin reaches gut)
Stool color	Pale/clay-colored (no stercobilin)
LFTs	Markedly elevated ALP and GGT; AST/ALT less prominent
Other	Pruritus (bile salt deposition in skin), steatorrhea, fat-soluble vitamin malabsorption

Causes:

Intrahepatic: Primary biliary cholangitis, primary sclerosing cholangitis, drugs, intrahepatic cholestasis of pregnancy
Extrahepatic: Choledocholithiasis, pancreatic carcinoma, cholangiocarcinoma, biliary strictures, ampullary carcinoma

Part 3: Hereditary Disorders of Bilirubin Metabolism

These are isolated bilirubin disorders without other liver disease:

Unconjugated Hyperbilirubinemia

Disorder	Defect	Bilirubin (mg/dL)	Phenobarbital response	Features
Crigler-Najjar Type I	Complete absence of UGT1A1	20-45	None	AR; kernicterus; requires phototherapy 12 h/day; liver transplant is curative
Crigler-Najjar Type II	Severely reduced UGT1A1 (<10% normal)	6-25	Yes (significant reduction)	AR; generally survives without brain damage; responds to phenobarbital
Gilbert Syndrome	Mildly reduced UGT1A1 (10-33% normal; usually UGT1A1*28 promoter variant)	1.5-4	Yes	Very common (~5% population); benign; exacerbated by fasting, illness, stress

Conjugated Hyperbilirubinemia

Disorder	Gene/Protein	Mechanism	Key Feature
Dubin-Johnson Syndrome	ABCC2/MRP2	Defective canalicular export of conjugated bilirubin	Black liver (lysosomal pigment); benign; coproporphyrin I in urine
Rotor Syndrome	SLCO1B1+SLCO1B3/OATP1B1+1B3	Defective hepatic reuptake of conjugated bilirubin refluxed from MRP3	No liver pigment; coproporphyrin I+III elevated
PFIC (Progressive Familial Intrahepatic Cholestasis)	ATP8B1 (FIC1), ABCB11 (BSEP), ABCB4 (MDR3)	Defective bile acid/lipid transport	Severe; progressive liver disease
BRIC (Benign Recurrent Intrahepatic Cholestasis)	ATP8B1 or ABCB11	Same genes as PFIC, less severe mutations	Episodic, self-limited cholestasis

Quick Diagnostic Summary

Jaundice
  │
  ├── Unconjugated (indirect) dominant
  │     ├── High urobilinogen, no bilirubinuria → PRE-HEPATIC (hemolysis)
  │     └── Normal urobilinogen, no bilirubinuria → HEPATIC (conjugation defect: Gilbert, Crigler-Najjar)
  │
  └── Conjugated (direct) dominant
        ├── Both fractions elevated, bilirubinuria → HEPATOCELLULAR (hepatitis, cirrhosis)
        └── Bilirubinuria + absent urobilinogen + pale stool → POST-HEPATIC (obstruction)

Sources:

Harrison's Principles of Internal Medicine, 22nd Edition (2025), Ch. 349
Goldman-Cecil Medicine, Ch. 133
Ganong's Review of Medical Physiology, 26th Edition, Ch. 28
Schwartz's Principles of Surgery, 11th Edition, Ch. 15

This is a shared conversation. Sign in to Orris to start your own chat.